Compounds > dazoxiben
Page last updated: 2024-08-23

dazoxiben and prostaglandin d2

dazoxiben has been researched along with prostaglandin d2 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertelé, V; Castagnoli, MN; Cerletti, C; de Gaetano, G; Rajtar, G1
Blair, IA; Lewis, PJ; Orchard, MA; Waddell, KA1
Bertelé, V; Cerletti, C; de Gaetano, G; Falanga, A; Tomasiak, M1
Bertelé, V; Cerletti, C; Chiabrando, C; de Gaetano, G; Falanga, A; Tomasiak, M1
Deckmyn, H; Gresele, P; Huybrechts, E; Vermylen, J1

Other Studies

5 other study(ies) available for dazoxiben and prostaglandin d2

ArticleYear
Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
    Biochemical pharmacology, 1985, Feb-01, Volume: 34, Issue:3

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Dinoprost; Dinoprostone; Drug Synergism; Humans; Imidazoles; Oxidoreductases; Platelet Aggregation; Prostaglandin D2; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Prostaglandins D; Prostaglandins E; Prostaglandins F; Prostanoic Acids; Thromboxane B2; Thromboxane-A Synthase

1985
Thromboxane synthase inhibition causes re-direction of prostaglandin endoperoxides to prostaglandin D2 during collagen stimulated aggregation of human platelet rich plasma.
    Thrombosis research, 1985, Sep-15, Volume: 39, Issue:6

    Topics: Blood Platelets; Collagen; Cyclooxygenase Inhibitors; Dinoprostone; Gas Chromatography-Mass Spectrometry; Humans; Imidazoles; In Vitro Techniques; Platelet Aggregation; Prostaglandin D2; Prostaglandin Endoperoxides; Prostaglandins D; Prostaglandins E; Thromboxane-A Synthase

1985
SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor.
    Thrombosis and haemostasis, 1984, Feb-28, Volume: 51, Issue:1

    Topics: Adenine; Adenylyl Cyclase Inhibitors; Blood Platelets; Cyclic AMP; Humans; Imidazoles; Oxidoreductases; Platelet Aggregation; Prostaglandin D2; Prostaglandins D; Thromboxane A2; Thromboxane-A Synthase

1984
Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase products.
    Blood, 1984, Volume: 63, Issue:6

    Topics: Adult; Arachidonic Acid; Arachidonic Acids; Chromatography, Gas; Chromatography, Thin Layer; Dinoprost; Dinoprostone; Female; Humans; Imidazoles; Male; Mass Spectrometry; Oxidoreductases; Platelet Aggregation; Prostaglandin D2; Prostaglandins D; Prostaglandins E; Prostaglandins F; Radioimmunoassay; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes

1984
Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2.
    Biochemical pharmacology, 1984, Jul-01, Volume: 33, Issue:13

    Topics: Adenine; Adult; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Female; Humans; Imidazoles; Male; Middle Aged; Oxidoreductases; Platelet Aggregation; Prostaglandin D2; Prostaglandins D; Serum Albumin; Thromboxane-A Synthase

1984